GHP Funds

SVP I

SVP I, the debut fund for the firm, closed in December 2002 and invested with four highly successful leveraged buyout funds. SVP I is diversified by sector and geography.

Learn More
SVP II

SVP II is a leveraged buyout fund of funds which closed in December 2006. SVP II represents a continuation of the successful strategy utilized by the predecessor fund, primarily investing with large, top tier LBO and growth equity firms. SVP II is diversified by sector and geography.

Learn More
SVP RE I

SVP Real Estate I, LP ("SVP RE I"), closed in February 2008, is a private real estate fund of funds. As with SVP I & II, SVP RE I received allocations with historically successful, highly sought after underlying fund managers who pursue compelling investment strategies. The fund is diversified by sector (Office, Hotel, Industrial/Warehouse, Retail and Residential) and geography (U.S., Europe, and Asia/Pacific).

Learn More
GHP COF

The GHP Credit Opportunity Fund (“GHP COF”) is a fund of alternative credit and distressed debt funds that is being raised and invested to pursue two specific investment themes: (1) the de-leveraging of European Banks, and (2) the potential for a distressed cycle in U.S. High Yield Credit. GHP COF will pursue complex liquid and illiquid credit opportunities in the U.S. and Europe.

Learn More

GHP Library

HelloMD Now Offers Nationwide Video Chat between Cannabis Patients and Doctors

HelloMD Extends HIPAA Compliant Video Chats, Between Cannabis Patients and Doctors, to all 50 States

Having connected more than 100,000 cannabis patients to doctors and nurse practitioners in California, New York, and Canada via online video, HelloMD now says “Hello!” to canna-curious patients nationwide.

LARKSPUR, Calif., March 6, 2019 /PRNewswire/ — HelloMD—the world’s largest online platform of cannabis patients, doctors and consumers—today announced the national launch of its MD video consultations, allowing canna-curious patients in all 50 states the opportunity to connect with doctors from the comfort of their own homes. Currently, 60 percent (approximately 300,000 unique visitors per month) of HelloMD’s online engagement comes from outside of California (the nation’s cannabis epicenter) showing that Americans are rapidly growing interest in learning about cannabis and CBD for physical, mental, and emotional wellness.

“HelloMD’s mission is to empower consumers to take charge of their health and wellness through education and expert guidance around cannabis and CBD consumption,” Co-founder Pamela Hadfield said. “And now, we can do our job even better by offering all of our visitors and 500,000-strong community direct access to the nation’s top cannabis and CBD doctors.”

Hailed as “the Quora meets WebMD of cannabis and CBD,” HelloMD was founded in 2014 in Silicon Valley and remains the world’s largest online wellness-oriented cannabis community as well as the nation’s first and only digital platform to provide HIPPA-compliant video chats between cannabis doctors and patients in every state.

To date, HelloMD doctors have collectively helped over 100,000 patients in California, New York, and Canada make informed decisions about cannabis and CBD. The digital healthcare platform offers today’s cannabis patients a full turnkey experience. Cannabis consumers can consult with a doctor via real-time video (with an average eight-minute wait time or less), obtain answers to questions from a network of doctors and experts, explore the most up-to-date research and studies available, and purchase the highest quality cannabis and hemp-derived CBD products on the market. HelloMD Marketplace ships hemp-derived CBD products nationwide and delivers THC products same-day to patients in California.

According to a January 2019 study conducted by BDS Analytics, Americans are now consuming cannabis and CBD less for social purposes and more to achieve enhanced mental, physical, and emotional wellbeing. Similarly, a 2017 survey consisting of 2,400 of HelloMD’s community members and conducted jointly with Brightfield Group—an independent market research firm focused on the legal cannabis industry—showed that 80 percent of CBD consumers surveyed said they found CBD to be very or extremely effective for treating insomnia, anxiety, depression, and chronic pain.

By expanding our video doctor consults to all 50 states and incorporating legal, non-toxic, 100 percent natural and third-party lab tested hemp CBD products into our online marketplace, HelloMD has the opportunity to be a resource to millions of struggling Americans.

Pamela Hadfield, Co-Founder

In record numbers, Americans are in physical and mental pain. Anxiety disorders affect 40 million adults in the U.S. every year. Depression is the leading cause of disability in the U.S. for people in their prime, and one-fifth of American adults are in chronic pain.

To schedule an online video consultation with a HelloMD doctor, learn about the many medicinal benefits of cannabis and CBD, or to purchase a HelloMD partner product, visit HelloMD.com. The doctor will see you now.

About HelloMD

HelloMD is one of the world’s largest online community of medical cannabis patients, experts, brands and trusted retailers, offering today’s cannabis patient a one-stop-shop experience. At HelloMD.com, medical cannabis consumers can consult with a doctor via real-time video, obtain answers to questions from a network of doctors and experts and research as well as purchase cannabis products from within the HelloMD Marketplace.

Say goodbye to pain, and say hello to HelloMD.

For more information about HelloMD, or to join its growing member community, visit www.hellomd.com or follow us on Facebook (@HelloMDcompany) and Twitter (@HelloMD_com).

Leave a Comment